A Study of DCC-2701 in Participants With Advanced Solid Tumors
NCT02228811
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Locally Advanced Tumors
Metastatic Solid Tumors
Cancers With MET Genomic Alterations
Cancers With TRK Genomic Alterations
Interventions
DRUG:
DCC-2701 tablet
Sponsor
Deciphera Pharmaceuticals, LLC